By Michael Kim
READ THE FULL BENF RESEARCH REPORT
In conjunction with a recent filing, Beneficient (NASDAQ:BENF) pre-announced expected GAAP revenues and net income for the fiscal year ended March 31, 2025. For F2025, GAAP revenue is expected to total approximately $(7.9) million, with net income attributable to BENF common shareholders of $51.2 million, with full financial results to be included in the upcoming 10-K filing.
While we continue to focus on adjusted business segment attributable to BENF equity holders’ financials, we note the fair value of Customer ExAlt Trusts investments came in at $291.4 million as of March 31, 2025, versus our prior $341 million forecast. As a result, we are lowering our adjusted segment revenue forecasts in light of lower Ben Liquidity interest income and Ben Custody fee assumptions.
On an adjusted business segment attributable to BENF equity holders basis, we now forecast net losses per Class A share of ($2.87) in F2025 (Mar) followed by ($0.42) for F2026, versus our prior estimates of ($2.85) and ($0.54), respectively. In addition, we are introducing a F2027 estimate of ($0.20) per Class A share. Notably, while our net loss forecast for F2026 widens, our net loss per share estimate narrows from ($0.54) to ($0.42) – entirely a function of a higher share count assumption reflecting accelerating loan originations.
Turning to valuation, we are taking down our price target to $2.00, reflecting our lower revenue outlook and a higher risk profile in our minds. Mr. Heppner’s recent resignation as Chief Executive Officer and Chairman of the Board of Directors adds uncertainty to the company’s strategic direction and ownership profile, particularly given the seemingly contentious nature of his departure, as well as Mr. Heppner’s holdings of Class B and preferred shares. That said, we still see considerable upside potential for the stock over time, though we recognize a meaningful upward revaluation likely necessitates sustained growth in loan origination volumes driving an inflection in profitability.
We highlight the following key takeaways from F4Q25:
1. CEO transition: On June 19, 2025, Brad Heppner resigned as Chief Executive Officer of Beneficient and Chairman of the company’s Board of Directors. According to company filings, Mr. Heppner’s resignation followed a request from the Audit Committee to participate in a formal interview to discuss documents linked to his relationship with a related entity previously provided to auditors in 2019. For background, Mr. Heppner founded Heritage Highland in 1996 to organize, acquire, and own operating companies – principally in the financial services, investment, and insurance sectors. In 2003, Mr. Heppner organized Highland Consolidated Business Holdings, L.P., the predecessor-in-interest to Beneficient, and changed the company’s name to The Beneficient Company Group, L.P. in 2015. Given Mr. Heppner’s history founding the company and prior role as CEO, his departure introduces uncertainty as it relates to Beneficient’s business strategy, growth prospects, and ownership structure going forward.
Following Mr. Heppner’s resignation, the Board announced the separation of the Chairman and CEO roles, with the appointment of Thomas Hicks as Chairman and James Silk as interim Chief Executive Officer. Importantly, Mr. Hicks, a private equity veteran, has served on Beneficient’s Board since 2018, while Mr. Silk returns to the company following his previous stint as Chief Legal Officer from January 2020 to May 2024. Prior to joining the company, Mr. Silk served as a Partner at Willkie Farr & Gallagher LLP and as an attorney at A&O Shearman LLP.
Stepping back, Mr. Silk’s prior tenure at Beneficient likely accelerates his onboarding as interim CEO. Indeed, his understanding of the company’s unique business model, core value proposition, and the market opportunity seemingly paves the way for more fully leveraging Beneficient’s structure to enhance fee-based/recurring revenues. We expect the board to lay out specifics around the search process in the near term, including the potential for Mr. Silk to transition to the role of permanent CEO.
2. Ongoing loan originations: In mid-March, Beneficient announced the closing of a $1.4 million primary capital commitment to a private equity fund managed by 8F Asset Management in exchange for BENF convertible preferred stock. Following the closing of the transaction, BENF’s ExAlt loan portfolio grew by $1.4 million, with the company’s Tangible Book Value (TBV) accreting by ~$450,000. Subsequent to F4Q25 quarter end, the company announced additional transactions including primarily capital commitments to the Mendoza Ventures Growth Fund III, Cork & Vines Fund I, and Pulse Pioneer Fund. In aggregate, related commitments totaled $11.7 million, thereby driving further growth in BENF’s loan portfolio and TBV accretion. Looking ahead, we see accelerating demand for primary capital commitments given incremental Preferred Liquidity Provider Program Agreements (including recently established pacts with Mendoza Ventures Growth Fund III and Cork & Vines Fund I), as well as the considerable total addressable market. Indeed, recent data suggests funds coming to market and those recently launched that are currently raising capital are targeting approximately $330 billion of new capital.
3. Litigation settlement: As part of GWG’s bankruptcy process, the Litigation Trust filed a complaint against Beneficient alleging causes of action related to prior equity purchases and loans by GWG. On March 10, 2025, Beneficient entered into a binding settlement agreement with the Litigation Trust to resolve all claims in the GWG Litigation without any admission of fault, liability, or wrongdoing for an undisclosed amount – likely to be covered by Directors & Officers (D&O) insurance. Subsequently in mid-June, the Bankruptcy Court for the Southern District of Texas approved the settlement agreement – another step in the process of resolving all related claims (though the agreement remains subject to approval by the District Court for the Northern District of Texas). Assuming final approval, the settlement likely alleviates ongoing litigation costs, regulatory scrutiny, and reputational harm, which in turn eases operational risks and uncertainties, thereby removing a lingering overhang on the stock in our minds.
SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website for additional information on Zacks SCR.
DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks SCR provides and Zacks SCR receives payments totaling a maximum fee of up to $50,000 annually for these services provided to or regarding the issuer. Full Disclaimer HERE.
